Many common neuropsychiatric disorders (e.g., Alzheimer's, schizophrenia, depression) may represent a number of different disorders that appear clinically similar, but respond differently to treatment. These underlying differences may reflect variable disease specific neural substrates. Thus, rapid identification of volumetric and shape abnormalities of specific brain areas relevant to the neuropathophysiology of such disorders would be helpful in characterizing disease subtypes and would most likely improve therapeutic outcomes. Identifying individuals with psychiatric and neurological disorders before the full onset of the symptoms of the disorders could allow for early intervention strategies aimed at preventing onset altogether and/or improving its long-term course.
Currently, decisions about morphology of brain structures in most clinical centers are restricted to subjective review of MRI images because of the labor-intensive nature of manual parcellation of MRI brain volumes and the lack of highly accurate and time efficient automatic tools. In addition, physicians are often concerned with a single brain structure at a time. However, the brain is an interconnected network of tissues. Thus, the investigation of multiple structures simultaneously may reveal important information that has the potential to shed new insights to important questions.
A method for identifying an abnormality of an anatomical structure by comprising segmenting, using a processor, the anatomical structure imaged in a volumetric image of a plurality of control patients to produce a control segmentation of the anatomical structures of each of the control patients, obtaining a normative dataset by extracting a statistical representation of a morphology of the control segmentations, segmenting the anatomical structure of a patient being analyzed for abnormalities to produce a patient segmentation, and comparing the patient segmentation to the normative dataset obtained from the control segmentations.
A system for identifying abnormalities of an anatomical structure having a processor segmenting the anatomical structure imaged in a volumetric image of a plurality of control patients to produce a control segmentation of the anatomical structures of each of the control patients and obtaining a normative dataset by extracting a statistical representation of a morphology of the control segmentations, and wherein the processor segments the anatomical structure of a patient being analyzed for abnormalities to produce a patient segmentation to compare the patient segmentation to the normative dataset obtained from the control segmentations.
A computer-readable storage medium including a set of instructions executable by a processor. The set of instructions operable to segment the anatomical structure imaged in a volumetric image of a plurality of control patients to produce a control segmentation of the anatomical structures of each of the control patients and obtain a normative dataset by extracting a statistical representation of a morphology of the control segmentations.
The exemplary embodiments may be further understood with reference to the following description and the appended drawings, wherein like elements are referred to with the same reference numerals. The exemplary embodiments relate to a system and a method for identifying volume and shape abnormalities of areas in the brain. In particular, the exemplary embodiments generate a three-dimensional segmentation of patient brain structures, which are adapted to a volumetric image such as an MRI, to compare the segmentations to a normative dataset that includes a quantitative description of the volume and shape of brain structures in healthy individuals. It will be understood by those of skill in the art, however, that although the exemplary embodiments specifically describe the segmentation of brain structures, the systems and methods in the exemplary embodiments may be used to identify volume and shape abnormalities in any anatomical 3D structure in a volumetric image such as, for example, a CT and/or an ultrasound image.
As shown in
In a step 220, a normative dataset is obtained based on the deformable segmentation of the structures of the control patients, by extracting a statistical representation of the underlying morphology of the brain structures. The normative dataset will contain information pertaining to volume, shape and a quantitative description of a relationship between different brain structures in the healthy control patient(s), e.g., a statistical description based on mean and variance and/or range values. Complementary to MRI volumes, surfaces representing different brain structures can be used to describe the geometry of the structure exterior. For example, coordinates, voxel values and different shape descriptors (e.g., surface curvature, point displacements from mid-sagittal plane, local deformation of surface, etc.) provide a simple, quantitative description of the brain structure.
Descriptive portions of the normative dataset may further include tags, which may be selected by a user to display textual information regarding the brain structures. The textual information may correspond to other sources such as, for example, radiology reports, that may provide a more complete representation of the normative dataset. Thus, the tags permit variances, biases of the normative dataset to also be compared to a deformable segmentation of brain structures of a patient. It will be understood by those of skill in the art that the normative dataset is stored in the memory 108 such that the normative dataset may be utilized, as desired, for different patients at different times. It will also be understood by those of skill in the art that once the normative dataset has been obtained and stored in the memory 108, the normative dataset may be utilized at any time such that steps 230-290, as described below, may be initiated separately from the steps 210 and 220, as described above.
In a step 230, the deformable segmentation process 300 is applied to a patient whose brain structures are being analyzed to identify abnormalities, to produce a patient segmentation of the brain structure(s) of interest. The deformable segmentation process 300 for the patient is substantially similar to the method of deformable brain segmentation conducted on the healthy control patients in the step 210 and as described below in regard to
Where the user elects to identify abnormalities via the user input in the step 250, the processor determines values for parameters of interest related to, for example, a volume, shape, curvature and structure of the patient segmentation, in a step 260. The parameters of interest correspond to the types of data included in the normative dataset obtained in the step 220. In a step 270, the values of the parameters of interest of the patient segmentation are compared to the normative dataset obtained from the control segmentations. For example, coordinates, voxel values and other quantitative shape descriptors from the patient segmentation are compared to the values of the normative dataset obtained from the control segmentation. The brain structures of the patient segmentation may be compared individually, as selected by the user, or in the alternative, simultaneously, such that all of the segmented brain structures are analyzed at once. If statistical information is implied within the normative dataset it is possible to directly derive a probability measure of whether or not the structure of interest of the patient's brain is healthy.
In a step 280, results of the comparison between the patient segmentation and the normative dataset obtained from the control segmentation is displayed on the display 106. The displayed results of the comparison may be textual and/or visual. For example, the display 106 may list patient brain structures with identified abnormalities along with a description of the abnormalities. Alternatively, the display 106 may show the patient segmentation with visual indications indicating deviations and/or differences from normative dataset. The visual indications may be, for example, variations in color or color gradients, which can indicate a degree or level of deviation of the patient segmentation from the control segmentation. Different colors may be assigned deviation ranges. Alternatively, the color indications may exist as a color gradient such that levels of deviations are indicated by varying shades of a color.
In a step 290, the system 100 receives a user input via the user interface 104. The user may enter the user input, electing to store the patient segmentation along with comparison results, retrieve a previously stored patient segmentation, select a tag to view, indicate other user preferences, etc. It will be understood by those of skill in the art that although the method 200, as described above, shows that the user elects to compare the patient segmentation to the normative dataset via the user input in the step 250, the comparison may also be conducted automatically by the processor 102 immediately subsequent to the production of the patient segmentation. Thus, it will also be understood by those of skill in the art that the method 200 may also proceed directly from step 230 to the step 260.
In a step 320, the deformable model is displayed on the display 106, as shown in
In a step 350, each of the triangular polygons associated with a feature point is automatically moved toward the associated feature point such that vertices of each of the triangular polygons are moved toward the boundary of the structure of interest, deforming the deformable model to adapt to the structure of the interest in the volumetric image. The deformable model is deformed until a position of each of the triangular polygons corresponds to a position of the associated feature point and/or the vertices of the triangular polygon lie substantially along the boundary of the structure of interest, as shown in
It will be apparent to those skilled in the art that various modifications may be made to the disclosed exemplary embodiments and methods and alternatives without departing from the spirit or the scope of the spirit or the scope of the disclosure. Thus, it is intended that the present disclosure cover modifications and variations provided that they come within the scope of the appended drawings and their equivalents.
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/IB2011/050450 | 2/2/2011 | WO | 00 | 11/28/2012 |
Number | Date | Country | |
---|---|---|---|
61309543 | Mar 2010 | US |